No Data
No Data
Optimistic Investors Push Walvax Biotechnology Co., Ltd. (SZSE:300142) Shares Up 42% But Growth Is Lacking
The Consensus EPS Estimates For Walvax Biotechnology Co., Ltd. (SZSE:300142) Just Fell Dramatically
Walvax Biotechnology Co., Ltd. Just Missed EPS By 60%: Here's What Analysts Think Will Happen Next
Watson Bio: 2024 Semi-Annual Report
Watson Bio: 2024 Semi-Annual Report Summary
Walvax Biotechnology (300142.SZ): The net income for the first half of the year was 0.171 billion yuan, a year-on-year decrease of 62.53%.
gelonhui August 27th, walvax biotechnology (300142.SZ) released the interim report for the first half of 2024, with a total operating income of 1.433 billion yuan during the reporting period, a year-on-year decrease of 33.88%; net income attributable to shareholders of the listed company was 0.171 billion yuan, a year-on-year decrease of 62.53%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.146 billion yuan, a year-on-year decrease of 65.39%; basic earnings per share was 0.1066 yuan.
No Data
No Data